PL118308B1 - Process for preparing novel 6-aryl-s-triazolo/4,3-a/-pyrido/2,3-f/-1,4-diazepinesdo/2,3-ehf/-1,4-diazepinov - Google Patents
Process for preparing novel 6-aryl-s-triazolo/4,3-a/-pyrido/2,3-f/-1,4-diazepinesdo/2,3-ehf/-1,4-diazepinov Download PDFInfo
- Publication number
- PL118308B1 PL118308B1 PL1976223070A PL22307076A PL118308B1 PL 118308 B1 PL118308 B1 PL 118308B1 PL 1976223070 A PL1976223070 A PL 1976223070A PL 22307076 A PL22307076 A PL 22307076A PL 118308 B1 PL118308 B1 PL 118308B1
- Authority
- PL
- Poland
- Prior art keywords
- group
- carbon atoms
- formula
- triazolo
- pyrido
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT837275A AT350056B (de) | 1975-11-04 | 1975-11-04 | Verfahren zur herstellung von neuen pyrido- (2,3-f)-(1,4)-diazepinen, deren optischen isomeren und salzen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL118308B1 true PL118308B1 (en) | 1981-09-30 |
Family
ID=3604891
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1976223070A PL118308B1 (en) | 1975-11-04 | 1976-11-03 | Process for preparing novel 6-aryl-s-triazolo/4,3-a/-pyrido/2,3-f/-1,4-diazepinesdo/2,3-ehf/-1,4-diazepinov |
| PL1976193439A PL113803B1 (en) | 1975-11-04 | 1976-11-03 | Process for preparing novel 6-aryl-s-triazolo-/4,3-a/-pyrido-/2,3-f/-1,4-diazepines |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1976193439A PL113803B1 (en) | 1975-11-04 | 1976-11-03 | Process for preparing novel 6-aryl-s-triazolo-/4,3-a/-pyrido-/2,3-f/-1,4-diazepines |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US4110455A (enExample) |
| JP (1) | JPS5831351B2 (enExample) |
| AR (3) | AR217814A1 (enExample) |
| AT (1) | AT350056B (enExample) |
| AU (1) | AU504228B2 (enExample) |
| BE (1) | BE847952A (enExample) |
| CA (1) | CA1076111A (enExample) |
| CH (1) | CH630920A5 (enExample) |
| CS (1) | CS191181B2 (enExample) |
| DD (1) | DD128178A5 (enExample) |
| DE (1) | DE2649116A1 (enExample) |
| DK (1) | DK142324B (enExample) |
| EG (1) | EG12280A (enExample) |
| ES (2) | ES452969A1 (enExample) |
| FI (1) | FI62088C (enExample) |
| FR (1) | FR2330404A1 (enExample) |
| GB (1) | GB1562800A (enExample) |
| HU (1) | HU177422B (enExample) |
| IL (1) | IL50816A (enExample) |
| IN (1) | IN144289B (enExample) |
| MX (1) | MX4284E (enExample) |
| NL (1) | NL7612187A (enExample) |
| NO (1) | NO146470C (enExample) |
| PL (2) | PL118308B1 (enExample) |
| PT (1) | PT65787B (enExample) |
| RO (2) | RO77294A (enExample) |
| SE (1) | SE7612260L (enExample) |
| SU (2) | SU667137A3 (enExample) |
| YU (1) | YU269176A (enExample) |
| ZA (1) | ZA766620B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1185601A (en) * | 1981-02-27 | 1985-04-16 | Walter Hunkeler | Imidazodiazepines |
| DE3435973A1 (de) * | 1984-10-01 | 1986-04-10 | Boehringer Ingelheim KG, 6507 Ingelheim | Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung |
| US4798896A (en) * | 1988-01-19 | 1989-01-17 | American Home Products Corporation | Antipsychotic gamma-carboline N-oxides |
| WO2011123678A2 (en) * | 2010-03-31 | 2011-10-06 | Arqule, Inc. | Substituted benzo-pyrido-triazolo-diazepine compounds |
| WO2012075456A1 (en) | 2010-12-02 | 2012-06-07 | Constellation Pharmaceuticals | Bromodomain inhibitors and uses thereof |
| AR084070A1 (es) | 2010-12-02 | 2013-04-17 | Constellation Pharmaceuticals Inc | Inhibidores del bromodominio y usos de los mismos |
| EP2705039B1 (en) | 2011-05-04 | 2017-07-26 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
| WO2012174487A2 (en) | 2011-06-17 | 2012-12-20 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
| TWI602820B (zh) | 2012-06-06 | 2017-10-21 | 星宿藥物公司 | 溴域抑制劑及其用途 |
| EP2864336B1 (en) | 2012-06-06 | 2016-11-23 | Constellation Pharmaceuticals, Inc. | Benzo[b]isoxazoloazepine bromodomain inhibitors and uses thereof |
| CA2952830C (en) | 2014-06-20 | 2022-11-01 | Constellation Pharmaceuticals, Inc. | Crystalline forms of 2-((4s)-6-(4-chlorophenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT327917B (de) * | 1973-04-12 | 1976-02-25 | Degussa | Verfahren zur herstellung von neuen 5-aryl-pyrido- (b-6,7) -1,4-diazepinen und deren salzen |
| US4039551A (en) * | 1976-03-15 | 1977-08-02 | The Upjohn Company | 1-[(Hydroxyamino)methyl]-6-aryl-4H-s-triazolo[4,3-a][1,4]benzodiazepines |
-
1975
- 1975-11-04 AT AT837275A patent/AT350056B/de not_active IP Right Cessation
-
1976
- 1976-06-02 RO RO7697708A patent/RO77294A/ro unknown
- 1976-10-26 US US05/735,894 patent/US4110455A/en not_active Expired - Lifetime
- 1976-10-26 SU SU762414098A patent/SU667137A3/ru active
- 1976-10-27 FR FR7632326A patent/FR2330404A1/fr active Granted
- 1976-10-28 DE DE19762649116 patent/DE2649116A1/de not_active Withdrawn
- 1976-11-02 GB GB45476/76A patent/GB1562800A/en not_active Expired
- 1976-11-02 YU YU02691/76A patent/YU269176A/xx unknown
- 1976-11-02 DD DD7600195560A patent/DD128178A5/xx unknown
- 1976-11-02 IL IL50816A patent/IL50816A/xx unknown
- 1976-11-02 EG EG76673A patent/EG12280A/xx active
- 1976-11-03 FI FI763158A patent/FI62088C/fi not_active IP Right Cessation
- 1976-11-03 PL PL1976223070A patent/PL118308B1/pl unknown
- 1976-11-03 DK DK497076AA patent/DK142324B/da not_active IP Right Cessation
- 1976-11-03 BE BE6045743A patent/BE847952A/xx unknown
- 1976-11-03 PT PT65787A patent/PT65787B/pt unknown
- 1976-11-03 CH CH1386976A patent/CH630920A5/de not_active IP Right Cessation
- 1976-11-03 CS CS767096A patent/CS191181B2/cs unknown
- 1976-11-03 HU HU76DE927A patent/HU177422B/hu unknown
- 1976-11-03 PL PL1976193439A patent/PL113803B1/pl unknown
- 1976-11-03 SE SE7612260A patent/SE7612260L/xx not_active Application Discontinuation
- 1976-11-03 AR AR265336A patent/AR217814A1/es active
- 1976-11-03 MX MX765041U patent/MX4284E/es unknown
- 1976-11-03 RO RO7688309A patent/RO70245A/ro unknown
- 1976-11-03 NL NL7612187A patent/NL7612187A/xx not_active Application Discontinuation
- 1976-11-03 ES ES452969A patent/ES452969A1/es not_active Expired
- 1976-11-03 ES ES452971A patent/ES452971A1/es not_active Expired
- 1976-11-03 NO NO763739A patent/NO146470C/no unknown
- 1976-11-04 AU AU19311/76A patent/AU504228B2/en not_active Expired
- 1976-11-04 JP JP51132728A patent/JPS5831351B2/ja not_active Expired
- 1976-11-04 CA CA264,849A patent/CA1076111A/en not_active Expired
- 1976-11-04 ZA ZA766620A patent/ZA766620B/xx unknown
- 1976-11-17 IN IN2062/CAL/76A patent/IN144289B/en unknown
-
1977
- 1977-06-14 AR AR268053A patent/AR216916A1/es active
- 1977-06-14 AR AR268052A patent/AR216915A1/es active
- 1977-10-17 SU SU772532701A patent/SU676165A3/ru active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL118308B1 (en) | Process for preparing novel 6-aryl-s-triazolo/4,3-a/-pyrido/2,3-f/-1,4-diazepinesdo/2,3-ehf/-1,4-diazepinov | |
| US3329676A (en) | Fused 1, 4-diazepine ring systems | |
| US3417101A (en) | Fused ring compounds | |
| CH619953A5 (en) | Process for the preparation of diazepine derivatives | |
| PL125321B1 (en) | Process for preparing novel,condensed derivatives of pyrimidines | |
| PL113628B1 (en) | Process for preparing novel,substituted in position 11 5,11-dihydro-6h-pyrido/2,3-b//1,4/benzodiazepin-6-ones | |
| CA1134359A (en) | Substituted pyrido [1,2-a] pyrimidines | |
| PL143224B1 (en) | Method of obtaining novel compounds with heterocyclic diazo ring | |
| US4183932A (en) | Fused quinazolinones and preparation thereof | |
| US3654275A (en) | Quinoxalinecarboxamide antiinflammatory agents | |
| US3236856A (en) | Imidazole derivatives | |
| PL154813B1 (en) | Method of obtaining s enantiomeric derivatives of glutar amide | |
| US3272816A (en) | 7-amino-2, 4-dioxo-1, 2, 3, 4-tetrahydropyrido[2, 3-d]pyrimidines | |
| PL96107B1 (pl) | Sposob wytwarzania nowych pochodnych tienotriazolodwuazepiny | |
| PL141127B1 (en) | Method of obtaining bis-/piperazinylo or homopiperazinylo/-alkanes | |
| US3660406A (en) | 2-chloro-7-hydroxy-11-(1-piperazinyl)dibenz(b f)(1 4)oxazepines | |
| Trybulski et al. | 2-Benzazepines. 5. Synthesis of pyrimido [5, 4-d][2] benzazepines and their evaluation as anxiolytic agents | |
| PL80193B1 (enExample) | ||
| EP0050212B1 (de) | 5-Substituierte 9-Cyanmethylen-dithieno(3,4-b:4'.3'-e)-azepine, Verfahren zu ihrer Herstellung und diese enthaltende therapeutische Mittel | |
| TANAKA et al. | Studies on Anti-platelet Agents. IV. A Series of 2-Substituted 4, 5-Bis (4-methoxyphenyl) pyrimidines as Novel Anti-platelet Agents | |
| PL91641B1 (enExample) | ||
| US3846412A (en) | Dihydro-2-amino-isoquinolines and their derivatives | |
| US4302463A (en) | 1-Azaxanthone-3-carboxylic acids and their production | |
| US3705245A (en) | 7-amino - 2-chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepines acting on the central nervous system | |
| US4686219A (en) | 11-(Piperazin- or homopiperazin-1-yl)-5H-imidazo-(2,1-C)(1,4)benzodiazepines useful as anti-allergics |